3 Stocks To Watch As US Policy Risk Reshapes Healthcare And Defense
Government policy sensitive stocks are back in focus after fresh headlines around Donald Trump’s $10b IRS lawsuit, the scrapped $1.776b “lawfare” fund and questions over future tax enforcement. Legal and political moves like these can change the risk profile and revenue outlook for companies that rely on regulation, contracts or close interaction with public agencies. If you care about how policy decisions can affect your portfolio, this is a useful moment to reassess. The sections that follow break down 3 stocks from our Government Policy Sensitive Stocks screener that appear positively exposed to this latest news.
HawkEye 360 (HAWK)
Overview: HawkEye 360 is a US space-enabled defense technology company that runs its own constellation of satellites to collect and process radio frequency signals, turning them into intelligence for defense, intelligence and national security agencies in the US and allied countries. Its platform helps customers monitor maritime activity, track military radar and extremist communications, protect borders and GNSS navigation, and support tactical intelligence on the battlefield.
Operations: HawkEye 360 generates about US$144.5 million in revenue from Aerospace & Defense, with roughly US$85.7 million from US customers and US$58.8 million from international clients.
Market Cap: US$2.02b
HawkEye 360 operates at the intersection of space-based data and sensitive government spending, which is why the Trump IRS lawsuit headlines matter. If shifting attitudes to tax enforcement and federal oversight lead to more emphasis on surveillance, compliance and secure intelligence, a satellite based RF data specialist with US$49.8 million in recent quarterly revenue and fresh international contracts could experience changes in demand from US and allied agencies. The company is still loss making and relies on external borrowing, so execution and funding are real risks, especially with a premium P/S ratio and share price volatility. The stock also trades below some fair value estimates, which raises the question of what the market may be missing.
HawkEye 360 sits at the crossroads of government surveillance needs and premium valuation. Yet the real story could be how its contract profile stacks up against balance sheet risk. Get the full picture in the analysis report for HawkEye 360
Alignment Healthcare (ALHC)
Overview: Alignment Healthcare runs a consumer focused healthcare platform for US seniors, offering Medicare Advantage plans that bundle medical coverage, care coordination and member support into a single service. The company uses data and technology to tailor benefits and care plans to individual members while working closely with doctors and health systems.
Market Cap: US$3.08b
Alignment Healthcare sits at the heart of US government backed senior healthcare, so shifts in policy and enforcement around programs like Medicare matter directly to its revenue and margins. The company combines a tech enabled care model, strong Medicare Advantage Star Ratings and growing membership with a funding structure that leans on external borrowing and a premium valuation multiple. This raises the stakes if growth or regulatory terms fall short of expectations. Recent legal and regulatory headlines, including lawsuits on star ratings and a whistleblower allegation, underline how dependent Alignment is on consistent oversight and trust. For investors who want exposure to policy sensitive healthcare growth, the key question is whether Alignment’s platform and earnings trajectory justify those risks.
Alignment Healthcare’s Medicare Advantage engine is closely tied to policy, ratings and trust, which can either amplify growth or create pressure. See how those forces intersect in the 4 key rewards and 1 important warning sign
LifeStance Health Group (LFST)
Overview: LifeStance Health Group provides outpatient mental health care for children, adolescents, adults and older patients across the United States, offering psychiatric evaluations, medication management, psychological testing and therapy both in person and through virtual visits.
Operations: LifeStance generates about US$1.49b in revenue from mental health services in the United States.
Market Cap: US$4.17b
LifeStance Health Group sits at the intersection of rising demand for mental health care and extensive public and private insurance coverage, so any shift in federal oversight and benefits policy can matter for access, pricing and volume. The company already reports over US$1.49b in annual revenue and has turned profitable, yet it still carries funding risk from reliance on external borrowing, a relatively low current ROE and an inexperienced leadership bench, all alongside recent insider selling and index removals. For investors looking at policy sensitive healthcare, the key question is whether LifeStance’s scale, M&A pipeline and raised 2026 revenue guidance justify its valuation given that regulatory scrutiny, reimbursement terms and capital decisions could quickly change the earnings profile.
LifeStance Health Group’s scale and recent move into profitability could be masking a very different risk reward balance. See how the 2 key rewards and 1 important warning sign might change your view on its next chapter.
The three stocks covered here are only a starting point, with the full Government Policy Sensitive Stocks screener surfacing 36 more companies that share similar policy themes and financial profiles to analyze. To identify the highest conviction ideas, use Simply Wall St to filter the Government Policy Sensitive Stocks screener by catalysts such as government contracts, regulatory exposure and balance sheet risk, so you can align the narratives in this article with your own criteria.
Take Control of Your Investment Journey
If LifeStance Health Group or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Seeking Alternatives Before Everyone Else
Fresh ideas can move fast when momentum builds, and the best entry points often disappear once the crowd catches on. Scan these under the radar picks while it matters and consider them early.
- Spot companies with strong cash reserves and robust fundamentals using the curated list of solid balance sheet and fundamentals (45 results) before market momentum significantly changes valuations.
- Hunt for income opportunities that aim to keep payouts flowing with the hand picked 9 dividend fortresses while yields remain attractive.
- Track businesses focused on long term AI infrastructure demand with the 57 AI infrastructure stocks while they are still under the radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com